Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

NIH makes wary return to India

Nature volume 506, pages 143–144 (2014)Cite this article

Subjects

Some clinical trials funded by US agency resume, but strict regulations have put off others.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Sara Reardon
    View author publications

    Search author on:PubMed Google Scholar

Related links

Related links

Related links in Nature Research

India shakes up rules on clinical trials 2012-Aug-21

Failings exposed at India’s drug regulator 2012-May-18

Indian journals push for clinical-trial registration 2008-Apr-16

Related external links

Central Drugs Standard Control Organization

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reardon, S. NIH makes wary return to India. Nature 506, 143–144 (2014). https://doi.org/10.1038/506143a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/506143a

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing